Cubist Systematic Strategies’s Decibel Therapeutics, Inc. Common Stock DBTX Stock Holding History

Cubist Systematic Strategies’s Portfolio DBTX Stock Details DBTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10	Closed	-$39	–	4181
2023 Q2	$39	Sell	10 -561	-98%	-$2.06K	﹤0.01%	3394
2023 Q1	$1.72K	Sell	571 -231	-29%	-$798	﹤0.01%	3796
2022 Q4	$1.64K	Buy	+802	New	+$2.44K	﹤0.01%	4133

Other funds holding DBTX

ACA

Atlas Capital Advisors Jackson, Wyoming $875M AUM

Cubist Systematic Strategies's DBTX Position: Q3 2023 in Review

Cubist Systematic Strategies sold out of Decibel Therapeutics, Inc. Common Stock (DBTX) in Q3 2023, closing a stake of 10 shares — an estimated $39 sold.

Cubist Systematic Strategies first reported a position in DBTX in Q4 2022 and held it in 3 quarters. The position peaked at $1.72K in Q1 2023. 1 fund tracked by Wall St. Rank holds DBTX as of Q3 2023.

Cubist Systematic Strategies reported no remaining Decibel Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Cubist Systematic Strategies sold 10 Decibel Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $39.
Cubist Systematic Strategies first reported a position in Decibel Therapeutics, Inc. Common Stock in Q4 2022 and held it in 3 quarters.
Cubist Systematic Strategies's Decibel Therapeutics, Inc. Common Stock position peaked at $1.72K in Q1 2023.
1 fund tracked by Wall St. Rank held Decibel Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Cubist Systematic Strategies's 13F filing for Q3 2023, filed 14 Nov 2023.